Kkr Phorm Investors L.p. - Net Worth and Insider Trading

Kkr Phorm Investors L.p. Net Worth

The estimated net worth of Kkr Phorm Investors L.p. is at least $0 dollars as of 2024-10-11. Kkr Phorm Investors L.p. is the 10% Owner of Transphorm Inc and owns about 0 shares of Transphorm Inc (TGAN) stock worth over $0. Details can be seen in Kkr Phorm Investors L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kkr Phorm Investors L.p. has not made any transactions after 2024-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kkr Phorm Investors L.p.

To

Kkr Phorm Investors L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kkr Phorm Investors L.p. owns 1 companies in total, including Transphorm Inc (TGAN) .

Click here to see the complete history of Kkr Phorm Investors L.p.’s form 4 insider trades.

Insider Ownership Summary of Kkr Phorm Investors L.p.

Ticker Comapny Transaction Date Type of Owner
TGAN Transphorm Inc 2024-06-20 10 percent owner

Kkr Phorm Investors L.p. Latest Holdings Summary

Kkr Phorm Investors L.p. currently owns a total of 1 stock. Kkr Phorm Investors L.p. owns 0 shares of Transphorm Inc (TGAN) as of June 20, 2024, with a value of $0.

Latest Holdings of Kkr Phorm Investors L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TGAN Transphorm Inc 2024-06-20 0 5.10 0

Holding Weightings of Kkr Phorm Investors L.p.


Kkr Phorm Investors L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Kkr Phorm Investors L.p. has made a total of 2 transactions in Transphorm Inc (TGAN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Transphorm Inc is the sale of 24,411,968 shares on June 20, 2024, which brought Kkr Phorm Investors L.p. around $125 Million.

Insider Trading History of Kkr Phorm Investors L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kkr Phorm Investors L.p. Trading Performance

GuruFocus tracks the stock performance after each of Kkr Phorm Investors L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kkr Phorm Investors L.p. is -22.71%. GuruFocus also compares Kkr Phorm Investors L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Kkr Phorm Investors L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kkr Phorm Investors L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kkr Phorm Investors L.p.

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.94 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -12.93 LIMIT LIMIT LIMIT LIMIT LIMIT

Kkr Phorm Investors L.p. Ownership Network

Ownership Network List of Kkr Phorm Investors L.p.

No Data

Ownership Network Relation of Kkr Phorm Investors L.p.

Insider Network Chart

Kkr Phorm Investors L.p. Owned Company Details

What does Transphorm Inc do?

Who are the key executives at Transphorm Inc?

Kkr Phorm Investors L.p. is the 10 percent owner of Transphorm Inc. Other key executives at Transphorm Inc include Chief Operating Officer Primit Parikh , director & Chief Executive Officer Mario Rivas , and director & Chief Technology Officer Umesh Mishra .

Transphorm Inc (TGAN) Insider Trades Summary

Over the past 18 months, Kkr Phorm Investors L.p. made 2 insider transaction in Transphorm Inc (TGAN) with a net sale of 22,675,980. Other recent insider transactions involving Transphorm Inc (TGAN) include a net sale of 14,352 shares made by Kelly Smales , a net sale of 13,179 shares made by Katharina G. Mcfarland , and a net sale of 6,000 shares made by Primit Parikh .

In summary, during the past 3 months, insiders sold 0 shares of Transphorm Inc (TGAN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,445,499 shares of Transphorm Inc (TGAN) were sold and 1,735,988 shares were bought by its insiders, resulting in a net sale of 22,709,511 shares.

Transphorm Inc (TGAN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Transphorm Inc Insider Transactions

No Available Data

Kkr Phorm Investors L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Kkr Phorm Investors L.p.. You might contact Kkr Phorm Investors L.p. via mailing address: C/o Kohlberg Kravis Roberts & Co. L.p., 30 Hudson Yards, New York Ny 10001.

Discussions on Kkr Phorm Investors L.p.

No discussions yet.